Transplant Infectious Disease

2.1(top 20%)

impact factor

2.8K(top 10%)

papers

50.2K(top 5%)

citations

78(top 10%)

h-index

2.4(top 20%)

extended IF

3.5K

all documents

53.5K

doc citations

107(top 10%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients	Transplant Infectious Disease	2010	390
2	The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants	Transplant Infectious Disease	2002	338
3	Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century	Transplant Infectious Disease	1999	257
4	Identifying the patient at risk for post‐transplant lymphoproliferative disorder	Transplant Infectious Disease	2001	234
5	European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL‐4 (2011)	Transplant Infectious Disease	2012	234
6	Outcome of treatment of Epstein–Barr virus‐related post‐transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases	Transplant Infectious Disease	2009	196
7	Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy	Transplant Infectious Disease	2010	161
8	Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON�-CMV	Transplant Infectious Disease	2007	155
9	Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease	Transplant Infectious Disease	2001	151
10	Pre‐ and post‐engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients	Transplant Infectious Disease	2005	149
11	Acute graft pyelonephritis following renal transplantation	Transplant Infectious Disease	2006	147
12	Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort	Transplant Infectious Disease	2012	146
13	Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center	Transplant Infectious Disease	2005	140
14	Infection with Klebsiella pneumoniae carbapenemase (KPC)‐producing K. pneumoniae in solid organ transplantation	Transplant Infectious Disease	2012	140
15	The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)	Transplant Infectious Disease	2016	140
16	Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity	Transplant Infectious Disease	2009	139
17	Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant‐Associated Infection Surveillance Network (TRANSNET)	Transplant Infectious Disease	2014	138
18	Safety and tolerability of caspofungin acetate in the treatment of fungal infections	Transplant Infectious Disease	2002	136
19	Cryptococcal meningitis: an analysis among 5521 consecutive organ transplant recipients	Transplant Infectious Disease	2002	129
20	Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir	Transplant Infectious Disease	2007	129
21	The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approach	Transplant Infectious Disease	2001	128
22	Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case–control study	Transplant Infectious Disease	2003	125
23	Retrospective study of the hepatic safety profile of patients concomitantly treated with caspofungin and cyclosporin A	Transplant Infectious Disease	2004	125
24	Infection in solid organ transplantation	Transplant Infectious Disease	1999	124
25	Blastomycosis in solid organ transplant recipients	Transplant Infectious Disease	2007	124
26	Infections after T‐replete haploidentical transplantation and high‐dose cyclophosphamide as graft‐versus‐host disease prophylaxis	Transplant Infectious Disease	2015	124
27	Etiologic agents of diarrhea in solid organ recipients	Transplant Infectious Disease	2007	120
28	Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10‐year, single‐center experience	Transplant Infectious Disease	2013	120
29	Mechanisms of human cytomegalovirus (HCMV) (re)activation and its impact on organ transplant patients	Transplant Infectious Disease	1999	119
30	Infections of the central nervous system in transplant recipients	Transplant Infectious Disease	2000	119
31	Epidemiology of fungal infections in solid organ transplant patients	Transplant Infectious Disease	1999	118
32	Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients	Transplant Infectious Disease	2010	118
33	Multidrug resistant gram‐negative bacilli as predominant bacteremic pathogens in liver transplant recipients	Transplant Infectious Disease	2009	117
34	Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis	Transplant Infectious Disease	2002	116
35	Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis	Transplant Infectious Disease	2009	116
36	Comparison of conventional and molecular detection of respiratory viruses in hematopoietic cell transplant recipients	Transplant Infectious Disease	2009	116
37	Rapid diagnosis of invasive aspergillosis by antigen detection	Transplant Infectious Disease	2003	115
38	The Epstein–Barr virus and post‐transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis	Transplant Infectious Disease	2001	114
39	Hospitalizations for fungal infections after renal transplantation in the United States	Transplant Infectious Disease	2001	114
40	Non‐tuberculous mycobacterial infection among lung transplant recipients: a 15‐year cohort study	Transplant Infectious Disease	2012	114
41	Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis	Transplant Infectious Disease	2000	113
42	Polyomavirus-associated nephropathy: update on BK virus-specific immunity	Transplant Infectious Disease	2006	113
43	Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation	Transplant Infectious Disease	2009	110
44	Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation	Transplant Infectious Disease	2009	109
45	Incidence, risk factors, and outcome of bloodstream infections during the pre‐engraftment phase in 521 allogeneic hematopoietic stem cell transplantations	Transplant Infectious Disease	2014	109
46	Variation in antifungal prophylaxis strategies in lung transplantation	Transplant Infectious Disease	2006	108
47	A multicenter study of histoplasmosis and blastomycosis after solid organ transplantation	Transplant Infectious Disease	2012	106
48	Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area	Transplant Infectious Disease	2002	105
49	Infectious complications of lung transplantation	Transplant Infectious Disease	2001	104
50	Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability	Transplant Infectious Disease	1999	103

Scientometrics

Overviews

Citing Bodies

Transplant Infectious Disease

Top Articles